Method for retarding progression to definite rheumatoid arthritis in subjects with undifferentiated arthritis
US8435952B2 · kind B2 · utility
9Cited by
23References
12Claims
0Family size
Inventors
Key dates
| Filing date | Feb 10, 2011 |
| Grant date | May 7, 2013 |
| Priority date | — |
| Expiry date | Jul 24, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.